IQVIA Holdings Inc.

IQV · Healthcare · · USD

209.62 USD

+0.00 (0.31%)

● Updated 2026-07-10 17:08 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 60

Trend & RS 84

Momentum 59

Fundamental 56

Macro 71

Liquidity 35

Component	Score	Weight
Technical	60.0	20%
Trend & RS	84.3	30%
Momentum	58.6	15%
Fundamental	55.6	10%
Macro	71.2	20%
Liquidity	35.4	5%

Trade Setup

Entry	209.16
Stop Loss	195.74 (6.4%)
Target 1 (1:1)	222.57 (+6.4%)
Target 2 (2:1)	236.00 (+12.8%)

ATR(14)	6.71 (3.2%)
Risk per Share	13.42
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	49.7	-0.01
Momentum	58.6	+0.35
Quality	36.2	-0.55
Composite	48.2

Quality Scores

Piotroski F-Score 5 /9 — Average

✓ ✓ ✗ ✗ ✗ ✗ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Overvalued

Metric	Stock	Sector	vs Peers
P/E Ratio	26.0	22.0	+18% above
P/B Ratio	5.6	4.0	Above

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

130.46

Market Price

209.62

Upside

-37.8%

Margin of Safety	-60.7%
Stage 1 PV (5yr FCF)	5,286,080,826
Terminal Value PV	16,487,949,183
Total Enterprise Value	21,774,030,009

Assumptions

Base FCF	1,074,836,015
Growth Rate (5yr)	8.4%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

44.28%

Full Kelly

22.14%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 68/100. Estimated win rate 60%, avg win 9.1%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary BUY

Bullish Signals

Bearish Signals

70.16

RSI(14)

8.5245

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↑ RISING (+12.8% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	Near 3-month high 3d since high
Sector Outperformance	+20.4% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	70.16	OVERBOUGHT
Macd	8.5245	BULLISH
Ma Cross	180.29 / 195.89	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.04x	LOW

Key Levels

Level	Price
52-Week High	247.05
Bollinger Upper	219.19
SMA(200)	195.89
SMA(50)	180.29
SMA(20)	189.68
Current Price	209.62
Bollinger Lower	160.17
52-Week Low	154.50
ATR(14)	6.71

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	0.58x	Normal bar — no special VSA pattern
2026-07-07	Normal	0.87x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.67x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.71x	Normal bar — no special VSA pattern
2026-07-10	No Demand	0.04x	Low volume, narrow spread, weak close — no buying interest

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	200.01	Above Kijun
Kijun-sen (26)	186.66	Base line
Senkou A	193.33	Leading span A
Senkou B	182.80	Leading span B
Cloud	182.80 – 193.33	Bullish (Green)
Price vs Cloud	209.16	Above Cloud
Chikou Span	182.05	Bullish
Alignment Score	4/4	BULLISH